Santagata Davide: Atypical Vascular Events Revealing Underlying Clonal Autoinflammation
Santagata Davide, Resident in Internal Medicine at University of Insubria, shared a post on LinkedIn about the recent article published in Internal and Emergency Medicine, co-authored by him and his colleagues, adding:
“Sometimes an unusual thrombosis is much more than a vascular event.
We are excited to share our new case report published in Internal and Emergency Medicine
‘Idiopathic splanchnic vein thrombosis unmasking a clonal autoinflammatory disease’
In this case, extensive splanchnic vein thrombosis was the first major clue to an underlying VEXAS syndrome, later confirmed by UBA1 mutation testing.
The report underlines three key clinical messages: unusual-site thrombosis may hide a systemic hematologic/autoinflammatory disorder, the peripheral blood smear can offer an early and accessible diagnostic clue, and management often requires balancing anticoagulation with inflammation control.
Congratulations to all co-authors for this collaborative work.”
Title: Idiopathic splanchnic vein thrombosis unmasking a clonal autoinflammatory disease
Authors: Davide Santagata, Matteo Molteni, Elena Epis, Francesco Dentali, Leonardo Campiotti

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines
-
Nov 15, 2026, 20:50Asmaa Beltagy: Efficacy and Safety of Eltrombopag in SLE-Associated Immune Thrombocytopenia
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP